Shu‐Yung Lin
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Tuberculosis Research and Epidemiology 6
-
- Diagnosis and treatment of tuberculosis 4
- Infectious Diseases and Tuberculosis 3
-
- Glycosylation and Glycoproteins Research 3
- Epigenetics and DNA Methylation 3
-
- Lung Cancer Treatments and Mutations 3
-
- Cancer Research and Treatments 2
- Co-authors
- Chong‐Jen YuHsing-Chen TsaiChao‐Chi HoHsuan‐Hsuan LuChia‐Lin HsuWon‐Young LeeChih‐Hsien WangSheng‐Hong Tseng
- Partner nations
- TaiwanUnited States
In The Last Decade
Shu‐Yung Lin
21 papers receiving 295 citations
Peers
Comparison fields: 5 of 53
- Critical Care and Intensive Care Medicine 19
- Oncology 95
- Immunology 72
- Neurology 39
- Epidemiology 86
Countries citing papers authored by Shu‐Yung Lin
This map shows the geographic impact of Shu‐Yung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Yung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Yung Lin more than expected).
Fields of papers citing papers by Shu‐Yung Lin
This network shows the impact of papers produced by Shu‐Yung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Yung Lin. The network helps show where Shu‐Yung Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu‐Yung Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 25 | |
| 7 | 2021 | 22 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 28 | |
| 10 | 2019 | 11 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 44 | |
| 14 | 2017 | 8 | |
| 15 | 2017 | 11 | |
| 16 | 2016 | 4 | |
| 17 | 2015 | 67 | |
| 18 | 2003 | 26 | |
| 19 | Cavernoma of the central nervous system: Surgical experience in the magnetic resonance imaging era | 1997 | 1 |
| 20 | 1994 | 29 |
About Shu‐Yung Lin
Shu‐Yung Lin is a scholar working on Infectious Diseases, Immunology and Biotechnology, having authored 24 papers that have together received 300 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Diagnosis and treatment of tuberculosis (4 papers), Glycosylation and Glycoproteins Research (3 papers), Epigenetics and DNA Methylation (3 papers), Infectious Diseases and Tuberculosis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Research and Treatments (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (19 citations), Oncology (95 citations) and Immunology (72 citations). Shu‐Yung Lin has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Chong‐Jen Yu, Hsing-Chen Tsai, Chao‐Chi Ho, Hsuan‐Hsuan Lu, Chia‐Lin Hsu, Won‐Young Lee, Chih‐Hsien Wang, Sheng‐Hong Tseng, Jin‐Yuan Shih and Feng‐Ming Tien.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.